Erythrocyte oxidant/antioxidant status of diabetic patients

Journal of Endocrinological Investigation

Volumn 23, Issue 4, 2000, Pages 228-230

  Buyukkocak S ^a   Ozturk H S ^a   Tamer, M N ^a   Kacmaz M ^a   Cimen M Y B ^a   Durak, I ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Antioxidant potential; Diabetes mellitus; Erythrocyte

Indexed keywords

ANTIHYPERTENSIVE AGENT; FREE RADICAL; ORAL ANTIDIABETIC AGENT;

ADULT; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ERYTHROCYTE; HUMAN; HYPERGLYCEMIA; OXIDATION REDUCTION POTENTIAL; OXIDATIVE STRESS;

EID: 0343238972     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03343712     Document Type: Article

References (12)

1. Sundaram R.K., Bhaskar A., Vijayalinbam S., Viswanathan M., Mohan R., Shantnugasundaram K.R. Antioxidant status and lipid peroxidation in type II diabetes, mellitus with and without complications. Clin. Sci. 1996, 90: 255-260.
2. Uzel N., Sivas A, Uysal M., Oz H. Erythrocyte lipid peroxidation and glutathione peroxidase activities in patients with diabetes mellitus Horm. Metabol. Res. 1987, 19: 89-90.
3. Haffner S.M., Agil A., Mykkanen L., Stern M.P., Jialal I. Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDMT. Diabetes Care 1995, 18: 646-653.
4. Selvam R., Anuradha C.V. Lipid peroxidation and antiperoxidative enzyme changes in erythrocytes in diabetes mellitus. Indian J. Biochem. Bio. 1988, 25: 268-272.
5. Willems D., Dorchy H., Dufrasne D. Serum antioxidant status and oxidized LDL in well-controlled young type 1 diabetic patients with and without subclinical complications. Atherosclerosis 1998, 137 (Suppl.): S61-S64.
6. Durak İ, Karabacak H.İ., Büyükkoçak S., Cimen M.Y.B., Kaçmaz M., Ömeroǧlu E., Öztürk H.S. Impaired antioxidant defense system in the kidney tissues from rabbits treated with cyclosporine. Nephron 1998, 78: 207-211.
7. Van Ye T.M., Roza A.M., Pieper G.M., Henderson Jr. J., Johnson C.P., Adams M.B. Inhibition of intestinal lipid peroxidation does not minimize morphological damage J. Surg. Res. 1993, 55: 553-558.
8. Loebstein R., Lehotay D.C., Luo X., Bartfay W., Tyler B., Sher G.D. Diabetic nephropathy in hypertransfused patients with beta-thalassemia. The role of oxidative stress. Diabetes Care 1998, 21: 1306-1309.
9. Zukowska-Szczechowska E., Grzeszczak W., Lacka B. The role of oxidative stress in development of diabetic angiopathies. Wiad. Lek. 1998, 51 (Suppl.) 2: 35-39.
10. Ceriello A., Bortolotti N., Motz E., Crescentini A., Lizzio S., Russo A., Tonutti L., Taboga C. Meal-generated oxidative stress in type 2 diabetic patients. Diabetes Care 1998, 21: 1529-1533.
11. Delmas-Beauvieux M.C., Peuchant E., Thomas M.I., Dubourg L., Pinto A.P., Clerc M. Gin H. The place of electron spin resonance methods in the detection of oxidative stress in type 2 diabetes with poor glycemic control. Clin. Biochem. 1998, 31: 221-228.
12. Losada M., Alio J.L Malondialdehyde serum concentration in type 1 diabetic with and without retinopathy. Doc. Ophthalmol. 1996/97, 93: 223-229.